KCT0005141招募中未知
The efficacy and Safety of non-vItamiN K antaGonist oraL anticoagulants for intermEdiate stroke risk in patients with Atrial Fibrillation (SINGLE AF study)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 1,800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19?(Year) 至 80?(Year)（—）
- 性别
- All
入选标准
- •Age: 19~80 years old
- •- CHA2DS2-VASc score 1 for male or 2 for female among nonvalvular atrial fibrillation patients
- •- Patients who agree to register for this study
- •- Patients who can be observed for the progress after treatment
排除标准
- •- Severe liver or kidney dysfunction
- •- Thyroid dysfunction
- •- Pregnant or breastfeeding women
- •- Malignant tumors that have not been completely cured
- •- Severe structural heart disease
- •- Predicted survival is less than 12 months
- •- Patients who do not understand the content of the study or disagree with it
研究者
相似试验
尚未招募
不适用
efficacy and safety of non vitamin K anticoagulants compared to vitamin K anticoagulants in treatment of atrial fibrillation patientsCTRI/2022/05/042669srm college of pharmacy
已完成
4 期
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)Atrial Fibrillation Patients With Intermediate Stroke RiskNCT04437654Yonsei University1,803
已完成
不适用
Prospective study of non-vitamin K antagonist oral anticoagulants (NOACs) management in Japanese patients with deep vein thrombosis and pulmonary embolism (DVT/PE)Venous thrombosisJPRN-UMIN000023747Department of Cardiology and Nephrology, Mie University Graduate School of Medicine1,000
招募中
2 期
A study to assess the safety of non-vitamin K antagonist oral anticoagulants on high-risk gastrointestinal endoscopic proceduresAll diseases that require high-risk gastrointestinal endoscopic procedures such as endoscopic polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection, endoscopic balloon dilation, endoscopic mucosal ablation or percutaneous endoscopic gastrostomyJPRN-UMIN000018284Osaka International Cancer Institute50
已完成
4 期
Vitamin K antagonist (VKA) therapy versus New Oral Anticoagulants (NOACs) therapy in patients with currently well controlled VKA therapy for non-valvular atrial fibrillation: a pilot studyatrial fibrillationcardiac arrhythmiaNL-OMON41389niversitair Medisch Centrum Groningen240